Covered recipient · General Payments record
CHRISTOPH J LEGE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,645.95
- Reported across 273 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.19 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $144.69 | 1 |
| ViiV Healthcare Company | $80.24 | 4 |
| ABBVIE INC. | $63.06 | 2 |
| Amgen Inc. | $26.18 | 1 |
| Abbott Laboratories | $24.93 | 1 |
| Theratechnologies Inc. | $24.56 | 1 |
| DEXCOM, INC. | $22.69 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.02 | 1 |
| PFIZER INC. | $15.44 | 1 |
| GlaxoSmithKline, LLC. | $15.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.93 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124978742 | CMS |
| ABBVIE INC. | $33.44 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104158238 | CMS |
| ABBVIE INC. | $29.62 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104158240 | CMS |
| Amgen Inc. | $26.18 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111632502 | CMS |
| Dexcom, Inc. | $22.69 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153292067 | CMS |
| GENZYME CORPORATION | $144.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139649632 | CMS |
| GlaxoSmithKline, LLC. | $15.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116437333 | CMS |
| Novartis Pharmaceuticals Corporation | $17.02 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087150558 | CMS |
| PFIZER INC. | $15.44 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131377726 | CMS |
| Theratechnologies Inc. | $24.56 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092903311 | CMS |
| ViiV Healthcare Company | $19.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112826777 | CMS |
| ViiV Healthcare Company | $20.66 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112790296 | CMS |
| ViiV Healthcare Company | $19.52 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112816411 | CMS |
| ViiV Healthcare Company | $20.27 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112777254 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.